Radar › Screener › PYXS

PYXS

Pyxis Oncology, Inc.
PYXS stock: dilution — what the SEC filings say, updated every weekday morning.
Nasdaq · Pharmaceutical Preparations · EDGAR filings (CIK 1782223) · 5 signals · 1 setups · updated Sep 22, 2026

What the filings say Pressure ▼

The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K.

Radar 76 (high attention) · dilution pressure high · listing risk low · governance risk low · runway 4.4 mo · strongest signal: Offering (424B) (Aug 28, 2026)

What would confirm: 424B5/8-K announcing an offering, ATM sales disclosed in next 10-Q, or Form 4 sales by insiders ahead of it.
What would prove it wrong: Non-dilutive cash event (asset sale, grant, milestone payment), OCF turning positive, or shelf withdrawn (RW).

Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.

Get tomorrow's read on PYXS — free
One email every weekday morning: what changed across PYXS and ~1,400 other microcaps, every claim linked to the filing.
76Radar · attention score (0–100)
76Dilution pressure · financing + balance sheet
0Listing risk · exchange standards
28Governance risk · reporting, auditor, going concern

Setups

Independent filings stitched into a thesis, each with what would confirm and what would prove it wrong.

Forced-raise setup Pressure ▼ strength 0.85

The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K. Cash need (runway < 6 months) coexists with live selling machinery (shelf effective, offering (424b)). Base case is a discounted raise; the question is when, not if.

Would confirm: 424B5/8-K announcing an offering, ATM sales disclosed in next 10-Q, or Form 4 sales by insiders ahead of it.
Would invalidate: Non-dilutive cash event (asset sale, grant, milestone payment), OCF turning positive, or shelf withdrawn (RW).
Runway < 6 monthsShelf effectiveOffering (424B)

Analyst note

No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.

Pro on PYXS
Alerts
One email the morning PYXS files anything that matches your rules (types, minimum score, setups).
12-month history
Every signal and setup for PYXS back a year, not just 30 days — see how the current setup built.
Full analyst notes
What we noticed, evidence with links, what could prove us wrong, red-team caveats.
Full screener + CSV
All 892 flagged companies, same-day, sortable and exportable.
Get Pro · $18.85/mo founding rate   See a full Pro morning 35% off forever until Sept 30 · cancel any time

Balance sheet (XBRL)

$18.9Mcash + short-term investments as of Jun 30, 2026
4.4 moestimated runway (annualized 180-day YTD operating cash flow [companyfacts])
$11.4Mstockholders' equity as of Jun 30, 2026
$64.4Mpublic float (10-K cover)
83.4Mshares outstanding as of Aug 12, 2026 · was 63.4M May 8, 2026

Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 84 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.

Signal timeline

Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.

DateSignalEvidenceScore
Sep 8, 2026· Officer/director change 8-K Item 5.02 filed 2026-09-08 (accepted 07:39 ET) filing 28
Aug 28, 2026▼ Offering (424B) 424B2 prospectus supplement 2026-08-28; 0 prior 424B filings in 12m filing 51
Aug 27, 2026▼ Shelf effective EFFECT notice 2026-08-27 filing 21
Jun 30, 2026▼ Runway < 6 months ~4.4 months runway: liquidity $33,000,000 (cash $18,855,000 + investments $14,145,000) as of 2026-06-30, burn $89,639,944/yr (annualized 180-day YTD operating cash flow [companyfacts]) filing 36
Jun 30, 2026▼ Share count +25% Shares outstanding 63,355,482 (2026-05-08) -> 83,408,050 (2026-08-12), +32% filing 35

Other forced raise setups

SDST Stardust Power Inc. · GOVX GeoVax Labs, Inc. · MYSZ My Size, Inc. · SNTI Senti Biosciences Holdings, · GCTK Glucotrack, Inc. · SOAR Volato Group, Inc. · screener →

Not a subscriber yet? The free morning digest carries what changed and the top setups. Subscribe free → · Compare plans